Archive for August, 2010

Top ten most accessed articles in July

This month sees the following articles in MedChemComm that are in the top ten most accessed:-

Chemical space as a source for new drugs
Jean-Louis Reymond, Ruud van Deursen, Lorenz C. Blum and Lars Ruddigkeit
Med. Chem. Commun., 2010, 1, 30-38, DOI: 10.1039/C0MD00020E

Small molecule modulation of stem cells in regenerative medicine: recent applications and future direction
Timothy E. Allsopp, Mark E. Bunnage and Paul V. Fish
Med. Chem. Commun., 2010, 1, 16-29, DOI: 10.1039/C0MD00055H

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists
Julia M. Adam, Jim Cairns, Wilson Caulfield, Phillip Cowley, Iain Cumming, Morag Easson, Darren Edwards, Morag Ferguson, Richard Goodwin, Fiona Jeremiah, Takao Kiyoi, Ashvin Mistry, Elizabeth Moir, Richard Morphy, Jason Tierney, Mark York, James Baker, Jean E. Cottney, Andrea K. Houghton, Paul J. Westwood and Glenn Walker
Med. Chem. Commun., 2010, 1, 54-60, DOI: 10.1039/C0MD00022A

Silver nanoparticles—the real “silver bullet” in clinical medicine?
Kenneth K. Y. Wong and Xuelai Liu
Med. Chem. Commun., 2010, 1, 125-131, DOI: 10.1039/C0MD00069H

An absolute structure template for a unique voltage-gated sodium channel binding site
Rex A. Palmer, Brian S. Potter, Michael J. Leach, Terence C. Jenkins and Babur Z. Chowdhry
Med. Chem. Commun., 2010, 1, 45-49, DOI: 10.1039/C0MD00043D

Synthesis and biological activity of new pyridonediaryl ether non-nucleoside inhibitorsof HIV-1 reverse transcriptase
Joshua J. Kennedy-Smith, Nidhi Arora, J. Roland Billedeau, Jennifer Fretland, Julie Q. Hang, Gabrielle M. Heilek, Seth F. Harris, Donald Hirschfeld, Hassan Javanbakht, Yu Li, Weiling Liang, Ralf Roetz, Mark Smith, Guoping Su, Judy M. Suh, Armando G. Villaseñor, Jeffrey Wu, Dennis Yasuda, Klaus Klumpp and Zachary K. Sweeney
Med. Chem. Commun., 2010, 1, 79-83, DOI: 10.1039/C0MD00009D

Histamine H3receptor ligands with a 3-cyclobutoxy motif: a novel and versatile constraint of the classical 3-propoxy linker
Maikel Wijtmans, Frédéric Denonne, Sylvain Célanire, Michel Gillard, Saskia Hulscher, Christel Delaunoy, Nathalie Van houtvin, Remko A. Bakker, Sabine Defays, Julien Gérard, Luc Grooters, Delphine Hubert, Henk Timmerman, Rob Leurs, Patrice Talaga, Iwan J. P. de Esch and Laurent Provins
Med. Chem. Commun., 2010, 1, 39-44, DOI: 10.1039/C0MD00056F

Effect of particle shape on phagocytosisof CdTe quantum dot–cystinecomposites
Zhisong Lu, Yan Qiao, Xin Ting Zheng, Mary B. Chan-Park and Chang Ming Li
Med. Chem. Commun., 2010, 1, 84-86, DOI: 10.1039/C0MD00008F

Synthesis and NMDAreceptor affinity of dexoxadrolanalogues with modifications in position 4 of the piperidine ring
Ashutosh Banerjee, Roland Fröhlich, Dirk Schepmann and Bernhard Wünsch
Med. Chem. Commun., 2010, 1, 87-102, DOI: 10.1039/C0MD00017E

Synthesis and selective inhibition of human monoamine oxidasesof a large scaffold of (4,5-substituted-thiazol-2-yl)hydrazones Franco Chimenti, Daniela Secci, Adriana Bolasco, Paola Chimenti, Arianna Granese, Simone Carradori, Melissa D’Ascenzio, Matilde Yáñez and Francisco Orallo
Med. Chem. Commun., 2010, 1, 61-72, DOI: 10.1039/C0MD00014K

Why not take a look at the articles today and blog your thoughts and comments below.

Fancy submitting an article to MedChemComm? Then why not submit to us today or alternatively email us your suggestions.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Discovery of a promising anticancer compound

Hengmiao Cheng and colleagues have synthesised a compound through integration of structure based drug design (SBDD) and physical properties based optimization (PPBO) with in vivo and in vitro great efficacy.

Currently, this compound is being evaluated in human clinical trilas for the treatment of cancer.

Read more and comment on it here:

Hengmiao Cheng, Shubha Bagrodia, Simon Bailey, Martin Edwards, Jacqui Hoffman, Qiyue Hu, Robert Kania, Daniel R. Knighton, Matthew A. Marx, Sacha Ninkovic, Shaoxian Sun and Eric Zhang
Med. Chem. Commun., 2010, 1, 139-144
DOI: 10.1039/C0MD00072H
Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

RSC Spinks Symposium: Novel Therapeutics and Diagnostics in Alzheimer’s Disease

September 27th 2010 at the Chemistry Centre, Burlington House, London UK

Join in this discussion of the critical issues that underpin the future of both diagnostics and therapeutics for the treatment of Alzheimer’s Disease.

Register now

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

MedChemComm UK-China Symposium

We are delighted to announce the MedChemComm UK-China Symposium, which will take place on Monday 22nd November 2010 at The Chemistry Centre, London, UK.

This 1-day symposium will feature invited lectures by researchers working in academia and industry in the UK and China. Researchers and students with an interest in medicinal chemistry are welcome to attend. Speaking at the symposium will be:

Dr Jason Wong
Roche R&D Centre, China

Professor Chris Abell
University of Cambridge, UK

Dr Richard M Soll
WuXi AppTec, China

Dr Mark Bunnage
Pfizer, UK

Professor Fa-Jun Nan
Shanghai Institute of Materia Medica, CAS, China

Professor Paul Wyatt
University of Dundee, UK

Professor Zhenjun Yang
Peking University, China

More details, including details of how to register your attendance, are available on the symposium website at http://www.rsc.org/MCCSymp2010.

Student bursaries, provided by the RSC’s Organic Division and Biological & Medicinal Chemistry Sector are available.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)